CINC - CinCor Pharma GAAP EPS of -$0.51 beats by $0.06 November, 03 2022 09:21 AM CinCor Pharma Inc. CinCor Pharma press release ( NASDAQ: CINC ): Q3 GAAP EPS of -$0.51 beats by $0.06 . Cash and cash equivalents of $522.4M For further details see: CinCor Pharma GAAP EPS of -$0.51 beats by $0.06